WHITEPAPER: TARGETING THE SOURCE OF HALITOSIS WITH BLIS K12™
Halitosis (bad breath) can be a major source of embarrassment and social anxiety for some people. Bad breath is estimated to affect half the adult population at some time, to some extent. BLIS K12™ has been scientifically proven to inhibit bacteria that cause halitosis…
Back to School: Boosting kids’ immunity and fighting upper respiratory illness
Frequent illnesses among children can disrupt education, impact work schedules, and strain family harmony. explore the benefits of BLIS K12™ as a dietary supplement that supports kids’ immunity and fighting cold and flu.
Analysing the Expanding Market Size of Upper Respiratory Tract Infections
Upper respiratory tract infections (URTIs), such as the common cold and flu, have plagued humanity for centuries. These infections affect the nose, throat, ears and sinuses, and are primarily caused by viral and bacterial pathogens.
Unlocking the Power of a Balanced Oral Microbiome: The Gateway to Optimal Health
One crucial aspect that often goes overlooked when it comes to maintaining overall health, is the health of our oral microbiome.
Whitepaper: How BLIS K12™ stimulates an immune response in times of high need
Two new studies have revealed that BLIS K12™ stimulates the production of interferon gamma and immunoglobulin A (sIgA) levels in the mouth…
BLIS K12™ for Upper Respiratory Illnesses: Boosting Immune Health Naturally
Upper respiratory illnesses, such as the common cold and flu, have a significant impact on our daily lives. To combat these upper respiratory illnesses naturally, a potential solution may be closer than you think: BLIS K12™. T
Skin Microbiome & Cosmeceuticals Congress: Asia
John Hale the Chief Technology Officer of Blis will be speaking on the Skin Microbiome and BLIS Q24™ our patented and beneficial strain of bacteria for the skin.
BLIS TECHNOLOGIES WINS CAWTHRON INSTITUTE INNOVATION AWARD
This award recognises outstanding innovation demonstrated in any facet of the entrant’s business. Dunedin-based Blis Technologies develops and manufactures innovative probiotic solutions. Founded on the research of Professor John Tagg (University of Otago) the company was formed in 2000 to develop probiotic based solutions for human health applications. Blis launched its BLIS Q24TM Live Probiotic […]
White Paper: Improving overall Respiratory Health with BLIS K12™
Three independent studies reveal continued support that consumption of Streptococcus salivarius (BLIS K12™) is beneficial in reducing the frequency and length of respiratory illness caused by both viruses and bacteria.
BLIS at Vitafoods Asia
Jennifer Walker and Tim Howlett travelled to Bangkok, Thailand to represent BLIS Technologies at Vitafoods Asia.
